Gennex Laboratories Ltd.
BSE: 531739
₹10.50
₹0.06
(0.57%)
As on 18-Jun-2026 13:32IST
Market cap
₹254 Cr
Revenue (TTM)
₹177 Cr
P/E Ratio
12.1
P/B Ratio
1.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹20 Cr
-
ROE
10.5 %
-
ROCE
12.5 %
-
Industry P/E
34.2
-
EV/EBITDA
7.7
-
Debt to Equity
0
-
Book Value
₹9.2
-
EPS
₹0.8
-
Face value
1
-
Shares outstanding
242,947,674
10 Years Aggregate
CFO
₹-16.73 Cr
EBITDA
₹68.52 Cr
Net Profit
₹54.13 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Gennex Lab
| -26.6 | 10.3 | 11.8 | -17.1 | 15.3 | 10.5 | 5.0 |
|
BSE Healthcare
| 9.0 | 0.3 | 11.4 | 9.1 | 23.6 | 13.7 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Gennex Lab
| -16.6 | -5.3 | 163.1 | -42.2 | 123.7 | 83.9 | -29.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Gennex Lab
|
10.5 | 253.6 | 177.4 | 21.0 | 13.8 | 9.3 | 12.1 | 1.1 |
| 3,080.3 | 38,525.2 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 36.5 | 8.5 | |
| 8,429.0 | 21,301.5 | 2,275.6 | 187.5 | 10.3 | 22.9 | 113.6 | 24.4 | |
| 2,354.0 | 17,735.4 | 2,187.2 | 649.7 | 31.5 | 19 | 27.7 | 4.9 | |
| 1,839.6 | 10,962.0 | 1,403.2 | 185.1 | -- | 27.4 | 59.2 | 14.7 | |
| 1,433.8 | 19,540.8 | 3,129.4 | 647.4 | 26.9 | 18.1 | 31.5 | 5.0 | |
| 2,179.6 | 35,257.9 | 4,147.8 | 709.5 | 22.3 | 19.1 | 49.7 | 8.5 | |
| 4,520.5 | 20,590.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.5 | 4.9 | |
| 6,269.5 | 10,359.8 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31.7 | 19.8 | |
| 547.2 | 11,203.9 | 1,538.1 | 226.2 | 20.4 | 9 | 46 | 4.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Gennex Lab
Gennex Laboratories Limited engages in the manufacturing and selling of bulk drugs, intermediates, and biotech products in India and internationally. The company offers active pharmaceutical ingredients, including Guaifenesin; Methocarbamol;... Fluconazole; Phenazopyridine Hcl; Allopurinol; and Ketoconazole. Its pipeline products include Melitracen Hydrochloride; Flupentixol Di-Hydrochloride; Domperidone; Potassium Guaiacol Sulphonate; Mefenamic Acid; Melitracen; and Chlorphenesin. The company was formerly known as Prudential Pharmaceuticals Limited. Gennex Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India. Read more
-
Incorporated
1990
-
Chairman
--
-
Managing Director
Arihant Baid
-
Headquarters
Sangareddy, Telangana
-
Website
Looking for more details about Gennex Laboratories Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsClarification On Price Movement
26-May-2026No News & Announcements are available.
FAQs for Gennex Lab
What is the current share price of Gennex Laboratories Ltd Today?
The share price of Gennex Laboratories Ltd is ₹10.50 (BSE) as of 18-Jun-2026 13:32 IST. Gennex Laboratories Ltd has given a return of 15.3% in the last 3 years.
What is the current PB & PE ratio of Gennex Laboratories Ltd?
The P/E ratio of Gennex Laboratories Ltd is 12.09 times as on 17-Jun-2026, a 65 discount to its peers’ median range of 34.20 times.
The P/B ratio of Gennex Laboratories Ltd is 1.14 times as on 17-Jun-2026, a 76 discount to its peers’ median range of 4.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
15.12
|
1.51
|
|
2024
|
31.60
|
2.18
|
|
2023
|
16.00
|
1.24
|
|
2022
|
22.14
|
2.17
|
|
2021
|
11.69
|
1.25
|
What is the 52 Week High and Low of Gennex Laboratories Ltd?
The 52-week high and low of Gennex Laboratories Ltd are Rs 17.25 and Rs 7.05 as of 18-Jun-2026.
What is the market cap of Gennex Laboratories Ltd?
Gennex Laboratories Ltd has a market capitalisation of ₹ 254 Cr as on 17-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Gennex Laboratories Ltd?
Before investing in Gennex Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.